2000
DOI: 10.1006/clim.2000.4871
|View full text |Cite
|
Sign up to set email alerts
|

MHC-Class I Antigens Regulate Both the Function and the Survival of Human Peripheral Blood NK Cells: Role of Endogenously Secreted TNF-α

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
27
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 28 publications
0
27
0
Order By: Relevance
“…Previous studies by other groups have also shown that a subset of IL-2 activated NK cells undergo cell death following cross-linking of the CD16 receptor (Ortaldo et al 1995;Azzoni et al 1995). Addition of antibodies to CD56 or LFA-1 did not cause any decrease in NK cell cytotoxicity demonstrating the specificity of CD16 mAb signaling in mediating inhibition of NK cell cytotoxicity (Jewett and Bonavida 2000).…”
Section: Split Anergy In Il-2 Treated Nk Cells Is Induced After Theirmentioning
confidence: 85%
See 1 more Smart Citation
“…Previous studies by other groups have also shown that a subset of IL-2 activated NK cells undergo cell death following cross-linking of the CD16 receptor (Ortaldo et al 1995;Azzoni et al 1995). Addition of antibodies to CD56 or LFA-1 did not cause any decrease in NK cell cytotoxicity demonstrating the specificity of CD16 mAb signaling in mediating inhibition of NK cell cytotoxicity (Jewett and Bonavida 2000).…”
Section: Split Anergy In Il-2 Treated Nk Cells Is Induced After Theirmentioning
confidence: 85%
“…Treatment of NK cells with IL-2 and anti-CD16mAb also induced split anergy by significantly decreasing the NK cell cytotoxicity while increasing the cytokine secretion capabilities of NK cells. Furthermore, NK cells exhibited CD16 -CD56 dim/-CD69 + phenotype after treatment with the combination of IL-2 and anti-CD16mAb (Jewett et al 1997(Jewett et al , 2006(Jewett et al , 2008Jewett and Bonavida 2000). Loss of cytotoxicity in NK cells was significantly exacerbated when NK cells were either treated with F(ab) 0 2 fragment of anti-CD16 mAb with IL-2 or treated with a combination of MHC-Class I and anti-CD16 mAbs in combination with IL-2 while the same treatments resulted in an increased secretion of cytokines (Jewett and Bonavida 2000;2008).…”
Section: Split Anergy In Il-2 Treated Nk Cells Is Induced After Theirmentioning
confidence: 99%
“…Previous studies by other groups have also shown that a subset of IL-2 activated NK cells undergo cell death following crosslinking of the CD16 receptor (Azzoni et al, 1995;Ortaldo et al, 1995). Addition of antibodies to CD56 or LFA-1 did not cause any decrease in NK cell cytotoxicity, demonstrating the specificity of anti-CD16 monoclonal antibody (mAb) signaling in mediating inhibition of NK cell cytotoxicity (Jewett & Bonavida, 2000). Thus, we coined the term 'split anergy' for responses mediated by NK cells after their interaction with sensitive target cells or after the triggering of CD16 receptors by the antibody in combination with IL-2 treatment (Jewett & Bonavida, 1995Jewett et al, 1997;Jewett et al, 2006aJewett et al, , 2008 (Bonavida et al, 1993;Jewett & Bonavida, 1994.…”
Section: Cd56mentioning
confidence: 94%
“…Furthermore, NK cells exhibited a CD16 À CD56 dim/À CD69 + phenotype after treatment with the combination of IL-2 and anti-CD16 mAb (Jewett & Bonavida, 2000;Jewett et al, 1997Jewett et al, , 2006aJewett et al, , 2008. Loss of cytotoxicity in NK cells was significantly exacerbated when NK cells were either treated with F(ab)' 2 fragment of anti-CD16 mAb with IL-2 or treated with a combination of MHC Class I and anti-CD16 mAb in combination with IL-2, while the same treatments resulted in an increased secretion of cytokines (Jewett & Bonavida, 2000;Jewett et al, 2008). Based on our recent results, NKp46 mAb were also able to induce significant NK cell anergy in the presence and absence of IL-2 correlating with their increased expression on untreated and IL-2 treated NK cells (manuscript submitted).…”
Section: Cd56mentioning
confidence: 99%
“…β 2 m is a component of MHC class I molecule which is necessary for transport and surface expression of functional class I molecules of MHC in mice [17]. In human, coincubation of NK cells with MHC class-I-deficient target cells results in the induction of NK cell death and inhibition of NK cell cytotoxic activity [6], suggesting that MHC class I antigens regulate the function of NK cell [3,7]. Thus, the function of MHC class I antigens on target cells may be important for survival and function of the activated NK cells.…”
mentioning
confidence: 99%